UMIN ID: UMIN000001234
Registered date:08/07/2008
A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Non-small-cell lung cancer |
| Date of first enrollment | 2006/04/01 |
| Target sample size | 24 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Carboplatin+Paclitaxel |
Outcome(s)
| Primary Outcome | recommended dose of radiotherapy |
|---|---|
| Secondary Outcome | Toxicity, response, overall survival |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Pulmonary fibrosis Previous treatment of thoracic irradiation Active co-existing malignancy |
Related Information
| Primary Sponsor | West Japan Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shinichiro Nakamura |
| Address | Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan |
| Telephone | 06-6633-7400 |
| datacenter@wjog.jp | |
| Affiliation | West Japan Oncology Group WJOG datacenter |
| scientific contact | |
| Name | Takuhito Tada |
| Address | 1-4-3 Asahimachi Abenoku Osaka Japan |
| Telephone | 06-6645-3831 |
| Affiliation | Osaka City University Graduate School of Medicine Department of Radiology |